AKAN peer analysis
Akanda (AKAN) against its competitors: price, today's move, 1-year return and market value side by side.
AKAN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BBLG Bone Biologics | $0.33 | -18.75% | -80.88% | $1.10M |
| GCTK GlucoTrack | $1.39 | -32.20% | -99.28% | – |
| GNPX Genprex | $2.08 | -5.88% | -97.72% | $1.05M |
| HSCS HeartSciences | $2.12 | -5.97% | -31.23% | $10.20M |
| IMCC IM Cannabis | $0.57 | 2.75% | -98.55% | $343.15K |
| JAGX Jaguar Health | $0.38 | -9.96% | -99.96% | $5.03M |
| PRFX PRF Technologies | $0.78 | -0.53% | -83.17% | $63.02K |
| RDHL Redhill Biopharma | $0.38 | -1.60% | -64.95% | $1.18M |
| SHPH Shuttle Pharma | $4.53 | -4.83% | -80.39% | $21.58M |
| UPC Universe Pharmaceuticals | $1.51 | -1.31% | -59.63% | $953.96K |
| AKAN Akanda | $1.36 | 102.47% | -95.31% | $3.25M |
- AKAN's peers: BBLG (Bone Biologics), GCTK (GlucoTrack), GNPX (Genprex), HSCS (HeartSciences), IMCC (IM Cannabis), JAGX (Jaguar Health), PRFX (PRF Technologies), RDHL (Redhill Biopharma).
Updated 2026-11-16 22:43 UTC